BBA
VTVT icon

Baker Bros. Advisors’s vTv Therapeutics VTVT Stock Holding History

Baker Bros. Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.88M Hold
148,314
– – 0.03% 73
2025
Q4 		$5.93M Hold
148,314
– – 0.03% 71
2025
Q3 		$3.46M Buy
148,314
+51,000
+52% +$895K 0.03% 75
2025
Q2 		$1.46M Hold
97,314
– – 0.01% 79
2025
Q1 		$1.69M Hold
97,314
– – 0.02% 78
2024
Q4 		$1.34M Hold
97,314
– – 0.01% 87
2024
Q3 		$1.32M Hold
97,314
– – 0.01% 83
2024
Q2 		$1.72M Hold
97,314
– – 0.02% 83
2024
Q1 		$2.29M Buy
+97,314
New +$1.24M 0.03% 72

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $425M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return